Air cooler maker Symphony Limited on Thursday announced acquisition of Chinese air cooler company Munters Keruilai Air Treatment Equipment (Guangdong) Co. Ltd. (MKE) that owns the brand Keruilai, for Rs 1.5 cr.
Air cooler maker Symphony Limited on Thursday announced acquisition of Chinese air cooler company Munters Keruilai Air Treatment Equipment (Guangdong) Co. Ltd. (MKE) that owns the brand Keruilai, for Rs 1.5 cr.
News Corp. is in the “final phase” of talks to sell its Amplify Inc. education unit. Amplify was supposed to help News Corp. take advantage of growth in the market for digital education, which is gradually replacing print textbooks. After investing more than $1 billion in the business, results have been “disappointing,” Chief Financial Officer Bedi Singh said.
Nomad Holdings Ltd. said on Thursday that it had agreed to acquire the Continental Europe business of Findus Group, the British frozen food and seafood supplier, for 500 million pounds, or about $780 million.
Mylan NV , which is trying to buy drugmaker Perrigo through a $34 billion hostile tender offer, on Thursday lowered the level of support it requires from Perrigo shareholders to push through the takeover.
Roche is buying U.S. diagnostics firm GeneWEAVE BioSciences for up to $425 million, expanding the Swiss group's commitment to fighting so-called "superbugs" as the threat from drug-resistant microbes grows, reports.
News Corp. is in the “final phase” of talks to sell its Amplify Inc. education unit. Amplify was supposed to help News Corp. take advantage of growth in the market for digital education, which is gradually replacing print textbooks. After investing more than $1 billion in the business, results have been “disappointing,” Chief Financial Officer Bedi Singh said.
Nomad Holdings Ltd. said on Thursday that it had agreed to acquire the Continental Europe business of Findus Group, the British frozen food and seafood supplier, for 500 million pounds, or about $780 million.
Mylan NV , which is trying to buy drugmaker Perrigo through a $34 billion hostile tender offer, on Thursday lowered the level of support it requires from Perrigo shareholders to push through the takeover.
Roche is buying U.S. diagnostics firm GeneWEAVE BioSciences for up to $425 million, expanding the Swiss group's commitment to fighting so-called "superbugs" as the threat from drug-resistant microbes grows, reports.
No comments:
Post a Comment